tm logo
XERISOL
SEARCHED

on 01 Dec 2022

Last Applicant/ Owned by

XERIS PHARMACEUTICALS INC.

180 N LaSalle Street, Suite 1810Chicago IL 60601

US

Serial Number

2126619 filed on 03rd Jun 2021

Correspondent Address

3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY

ALBERTA

CA

T2P4H2

XERISOL

Trademark usage description

pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous syst Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders.


Classification kind code

11

Class [042]
Providing information on drug technology platforms for the formulation and development of drugs and biologics


Classification kind code

11

Mark Details


Serial Number

2126619

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 06th Mar 2023
Agent Changed
Submitted for opposition 22
on 01st Dec 2022
Search Recorded
Submitted for opposition 20
on 01st Dec 2022
Examiner's First Report
Submitted for opposition 223
on 01st Dec 2022
Total Provisional Refusal
Submitted for opposition 256
on 13th Jun 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 12th Aug 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 11th Aug 2021
Formalized
Submitted for opposition 1
on 11th Aug 2021
Created
Submitted for opposition 228
on 03rd Jun 2021
International Registration
Submitted for opposition 30
on 03rd Jun 2021
Filed